Skip to main content
Log in

Antiphospholipid antibodies in paediatrics

  • Review
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Antiphospholipid antibodies, i.e. circulating auto-antibodies to negatively charged phospholipids, are mainly observed in patients with systemic lupus erythematosus, but may also occur in individuals who lack evidence of a well-defined systemic disease. Several studies have suggested that they may play a direct role in the pathogenesis of recurrent vascular thrombosis, repeated abortions, and thrombocytopenia (socalled antiphospholipid antibody syndrome), although the mechanism by which this occurs is still poorly understood. The management of patients with antiphospholipid antibody-related thrombosis includes anti-aggregants, anticoagulants, corticosteroids, and cytotoxic drugs, but the optimum treatment is still controversial. Here we review the test systems used to detect antiphospholipid antibodies and their significance in paediatrics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

aCL :

anticardiolipin antibodies

aPL :

antiphospholipid antibodies

APS :

antiphospholipid antibody syndrome

BFP-STS :

biological false-positive serological test for syphilis

JCA :

juvenile chronic arthritis

LA :

lupus anticoagulant

PTT :

partial thromboplastin time

SLE :

systemic lupus erythematosus

STS :

standard tests for syphilis

VDRL :

Venereal Disease Research Laboratory

References

  1. Alarcón-Segovia D (1988) Pathogenetic potential of antiphospholipid antibodies. J Rheumatol 15: 890–893

    PubMed  Google Scholar 

  2. Alarcón-Segovia D, Cabral AR (1992) Functional and immunochemical heterogeneity of antiphospholipid antibodies: a classification. J Rheumatol 19: 1166–1169

    PubMed  Google Scholar 

  3. Appan S, Boey ML, Lim KW (1987) Multiple thromboses in systemic lupus erythematosus. Arch Dis Child 62: 739–741

    PubMed  Google Scholar 

  4. Asherson RA (1988) A “primary” antiphospholipid syndrome? J Rheumatol 15: 1742–1746

    PubMed  Google Scholar 

  5. Asherson RA (1993) SLE and the antiphospholipid antibody syndrome. J Rheumatol 20: 1801–1802

    PubMed  Google Scholar 

  6. Asherson RA, Cervera R (1992) The antiphospholipid syndrome: a syndrome in evolution. Ann Rheum Dis 51: 147–150

    PubMed  Google Scholar 

  7. Asherson RA, Chan JKH, Harris EN, Gharavi AE, Hughes GRV (1985) Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal. Ann Rheum Dis 44: 823–825

    PubMed  Google Scholar 

  8. Asherson RA, Baguley E, Pal C, Hughes GRV (1991) Antiphospholipid syndrome: five year follow up. Ann Rheum Dis 50: 805–810

    PubMed  Google Scholar 

  9. Berman L (1993) Primary antiphospholipid syndrome. J Rheumatol 20: 1802

    PubMed  Google Scholar 

  10. Bernstein ML, Salusinsky-Sternbach M, Bellefleur M, Esseltine DW (1984) Thrombotic and hemorrhagic complications in children with the lupus anticoagulant. Am J Dis Child 138: 1132–1135

    PubMed  Google Scholar 

  11. Bowie EJW, Thompson JH, Pascuzzi CA, Owen CA (1963) Thrombosis in systemic lupus erythematosus despite circulating anticoagulant. J Lab Clin Med 62: 416–430

    PubMed  Google Scholar 

  12. Burgio GR, Martini A (1990) Immunological features of diffuse connective tissue diseases. Eur J Pediatr 149: 224–231

    PubMed  Google Scholar 

  13. Caporali R, Ravelli A, De Gennaro F, Neirotti G, Montecucco C, Martini A (1991) Prevalence of anticardiolipin antibodies in juvenile chronic arthritis. Ann Rheum Dis 50: 599–601

    PubMed  Google Scholar 

  14. Caporali R, Ravelli A, Ramenghi B, Montecucco C, Martini A (1992) Antiphospholipid antibody associated thrombosis in juvenile chronic arthritis. Arch Dis Child 67: 1384–1386

    PubMed  Google Scholar 

  15. Conley CL, Hartmann RC (1952) Haemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest 31: 621–622

    Google Scholar 

  16. Contractor S, Hiatt M, Kosmin M, Kim HC (1992) Neonatal thrombosis with anticardiolipin antibody in baby and mother. Am J Perinatol 9: 409–410

    PubMed  Google Scholar 

  17. Cowchock S, Smith JB, Gocial B (1986) Antibodies to phospholipids and nuclear antigens in patients with repeated abortions. Am J Obstet Gynecol 155: 1002–1010

    PubMed  Google Scholar 

  18. Dungan DD, Jay MS (1992) Stroke in an early adolescent with systemic lupus erythematosus and coexistent antiphospholipid antibodies. Pediatrics 90: 96–99

    PubMed  Google Scholar 

  19. Ehrenstein MR, Swana M, Keeling D, Asherson R, Hughes GRV, Isenberg DA (1993) Anti-DNA antibodies in the primary antiphospholipid syndrome (PAPS). Br J Rheumatol 32: 362–365

    PubMed  Google Scholar 

  20. Exner T (1985) Similar mechanism of various lupus anticoagulants. Thromb Haemost 53: 15–18

    PubMed  Google Scholar 

  21. Falcini F, Taccetti G, Trapani S, Tafi L, Petralli S, Matucci-Cerinic M (1991) Primary antiphospholipid syndrome: a report of two pediatric cases. J Rheumatol 18: 1085–1087

    PubMed  Google Scholar 

  22. Galli M, Comfurius P, Maassen C, Hemker HC, De Baets MH, Van Breda-Vriesman PJC, Barbui T, Zwaal RFA, Bevers EM (1990) Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 335: 1544–1547

    Article  PubMed  Google Scholar 

  23. Harris EN (1987) Syndrome of the Black Swan. Br J Rheumatol 26: 324–326

    PubMed  Google Scholar 

  24. Harris EN (1990) A reassessment of the antiphospholipid syndrome. J Rheumatol 17: 733–735

    PubMed  Google Scholar 

  25. Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S, Hughes GRV (1983) Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet II: 1211–1214

    Article  Google Scholar 

  26. Harris EN, Gharavi AE, Hedge U, Derue G, Morgan SH, Englert H, Chan JKH, Asherson RA, Hughes GRV (1985) Anticardiolipin antibodies in autoimmune thrombocytopenic purpura. Br J Haematol 59: 231–234

    PubMed  Google Scholar 

  27. Harris EN, Khamashta MA, Hughes GRV (1991) Antiphospholipid antibody syndrome. In: Mc Carty DJ, Koopman WJ (eds) Arthritis and allied conditions, 12th edn. Lea and Febiger, Philadelphia, pp 1201–1212

    Google Scholar 

  28. Hughes GRV, Harris EN, Gharavi AE (1986) The anticardiolipin syndrome. J Rheumatol 13: 486–489

    PubMed  Google Scholar 

  29. Kelley RE, Berger JR (1987) Ischemic stroke in a girl with lupus anticoagulant. Pediatr Neurol 3: 58–61

    Article  PubMed  Google Scholar 

  30. Khamashta MA, Wallington T (1991) Management of the antiphospholipid syndrome. Ann Rheum Dis 50: 959–962

    PubMed  Google Scholar 

  31. Lechner K (1974) Acquired inhibitors in nonhemophilic patients. Haemostasis 3: 65–93

    PubMed  Google Scholar 

  32. Lie JT (1989) Vasculopathy in the antiphospholipid syndrome: thrombosis or vasculitis, or both? J Rheumatol 16: 713–715

    PubMed  Google Scholar 

  33. Loizou S, McCrea JD, Rudge AC, Reynolds R, Boyle CC, Harris EN (1985) Measurement of anticardiolipin antibodies by an enzyme linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol 62: 738–745

    PubMed  Google Scholar 

  34. Love PE, Santoro SA (1990) Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med 112: 682–698

    PubMed  Google Scholar 

  35. MacKay RJ, Menahem S, Ekert H (1982) Deep vein thrombosis in association with a circulating endogenous anticoagulant. J Pediatr 101: 75–78

    PubMed  Google Scholar 

  36. Mackworth-Young C (1990) Antiphospholipid antibodies: more than just a disease marker? Immunol Today 11: 60–65

    Article  PubMed  Google Scholar 

  37. Massa M, De Benedetti F, Ravelli A, Martini A (1993) Anti-DNA antibodies in the primary antiphospholipid syndrome. Br J Rheumatol 32: 1028

    Google Scholar 

  38. McNeil HP, Chesterman CN, Krilis SA (1989) Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics. Br J Haematol 73: 506–513

    PubMed  Google Scholar 

  39. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA (1990) Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2 glycoprotein-I (apolipoprotein H). Proc Natl Acad Sci USA 87: 4120–4124

    PubMed  Google Scholar 

  40. McNeil HP, Chesterman CN, Krilis SA (1991) Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 49: 193–280

    PubMed  Google Scholar 

  41. Montecucco C, Ravelli A, Caporali R, Viola S, De Gennaro F, Albani S, Martini A (1990) Autoantibodies in juvenile dermatomyositis. Clin Exp Rheumatol 8: 193–196

    PubMed  Google Scholar 

  42. Montes de Oca M, Babron MC, Blétry O, Broyer M, Courtecuisse V, Fontaine JL, Loirat C, Méry JP, Reinert P, Wechsler B, Levy M (1991) Thrombosis in systemic lupus erythematosus: a French collaborative study. Arch Dis Child 66: 713–717

    PubMed  Google Scholar 

  43. Moore JE, Mohr CF (1952) Biologically false positive serologic tests for syphilis. JAMA 150: 467–473

    Google Scholar 

  44. Olive D, André E, Brocard O, Labrude P, Alexandre P (1979) Lupus érythémateux disséminé revélé par des thrombophlébites des membres inferieurs. Arch Fr Pediatr 36: 807–811

    PubMed  Google Scholar 

  45. Ostuni PA, Lazzarin P, Pengo V, Ruffatti A, Schiavon F, Gambari P (1990) Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome. Ann Rheum Dis 49: 184–187

    PubMed  Google Scholar 

  46. Pelkonen P, Simell O, Rasi V, Vaarala O (1988) Venous thrombosis associated with lupus anticoagulant and anticardiolipin antibodies. Acta Paediatr Scand 77: 767–772

    PubMed  Google Scholar 

  47. Piette JC, Wechsler B, Frances C, Godeau P (1992) Systemic lupus erythematosus and the antiphospholipid syndrome: reflections about the relevance of ARA criteria. J Rheumatol 19: 1835–1837

    PubMed  Google Scholar 

  48. Piette JC, Wechsler B, Frances C, Papo T, Godeau P (1993) Exclusion criteria for primary antiphospholipid syndrome. J Rheumatol 20: 1802–1804

    PubMed  Google Scholar 

  49. Ravelli A, Caporali R, Bianchi E, Viola S, Solmi M, Montecucco C, Martini A (1990) Anticardiolipin syndrome in childhood: a report of two cases. Clin Exp Rheumatol 8: 95–98

    PubMed  Google Scholar 

  50. Ravelli A, Caporali R, Montecucco C, Martini A (1992) Superior vena cava thrombosis in a child with antiphospholipid syndrome. J Rheumatol 19: 502–503

    PubMed  Google Scholar 

  51. Ravelli A, Di Fuccia G, Caporali R, Malvezzi F, Montecucco C, Martini A (1993) Severe retinopathy in systemic lupus erythematosus associated with Ig anticardiolipin antibodies. Acta Paediatr 82: 624–626

    PubMed  Google Scholar 

  52. Ravelli A, Caporali R, Di Fuccia G, Zonta L, Montecucco C, Martini A. Anticardiolipin antibodies in pediatric systemic lupus erythematosus. Arch Pediatr Adolesc Med (in press)

  53. Roddy SM, Giang DW (1991) Antiphospholipid antibodies and stroke in an infant. Pediatrics 87: 933–935

    PubMed  Google Scholar 

  54. Rose CD, Goldsmith DP (1990) Childhood adrenal insufficiency, chorea, and antiphospholipid antibodies. Ann Rheum Dis 49: 421–422

    Google Scholar 

  55. Schousboe I (1985) Beta 2 glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 66: 1086–1091

    PubMed  Google Scholar 

  56. Shergy WJ, Kredich DW, Pisetsky DS (1988) The relationship of anticardiolipin antibodies to disease manifestations in pediatric systemic lupus erythematosus. J Rheumatol 15: 1389–1394

    PubMed  Google Scholar 

  57. Silver RK, MacGregor SN, Pasternak JF, Neely SE (1992) Fetal stroke associated with elevated maternal anticardiolipin antibodies. Obstet Gynecol 80: 497–499

    PubMed  Google Scholar 

  58. St Clair W, Jones B, Rogers JS, Crouch M, Hrabovsky E (1981) Deep venous thrombosis and a circulating anticoagulant in systemic lupus erythematosus. Am J Dis Child 135: 230–232

    PubMed  Google Scholar 

  59. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Green Schaller J, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271–1277

    PubMed  Google Scholar 

  60. Ura Y, Hara T, Mori Y, Matsuo M, Fujioka Y, Kuno T, Okue A, Miyazaki S (1992) Development of Perthes' disease in a 3-year-old boy with idiopathic thrombocytopenic purpura and antiphospholipid antibodies. Pediatr Hematol Oncol 9: 77–80

    PubMed  Google Scholar 

  61. Vlachoyiannopoulos PG, Dimou G, Siamopoulou-Mavridou A (1991) Chorea as a manifestation of the antiphospholipid syndrome in childhood. Clin Exp Rheumatol 9: 303–305

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ravelli, A., Martini, A. & Burgio, G.R. Antiphospholipid antibodies in paediatrics. Eur J Pediatr 153, 472–479 (1994). https://doi.org/10.1007/BF01956999

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01956999

Key words

Navigation